Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer

by Stephen T. Ryan, Jing Zhang, Danielle N. Burner, Michael Liss, Emily Pittman, Michelle Muldong, Ahmed Shabaik, Jason Woo, Nicole Basler, Jonathan Cunha, Shabnam Shalapour, Monica V. Estrada, Michael Karin, Karen Messer, Stephen Howell, Christopher J. Kane, Christina A. M. Jamieson
Published 2020-05-01